3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
84
Phase 1
54
Phase 3
45
Phase 1/2
31
Phase 2/3
3
Phase NA
2
Phase EARLY_PHASE1
2
Phase 4
2
Status
Recruiting
3
Completed
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Carcinoma, Non-Small-Cell Lung
2
Lung Neoplasms
1
Interventions
Zoledronic Acid
28
Saline Solution
26
Metformin
25
Dexamethasone
25
Cyclophosphamide
23
Cytarabine
22
Bupivacaine
20
Sodium Chloride
18
Vincristine
17
Methotrexate
17
Letrozole
17
Propofol
15
Morphine
15
Doxorubicin
15
Cisplatin
15
Prednisolone
14
Docetaxel
14
Dexmedetomidine
14
Bevacizumab
14
Oxycodone
13
Imiquimod
13
Fentanyl
13
Capecitabine
13
Rituximab
12
Mercaptopurine
12
Fluorouracil
12
Granulocyte Colony-Stimulating Factor
11
Everolimus
11
Asparaginase
11
Acetaminophen
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Completed
×
atezolizumab
×
Clear all
NCT03285763
2025-01-23
TAIL
Hoffmann-La Roche
Phase 4
Completed
619 enrolled
22 charts
NCT04059887
2023-02-08
BUDDY
Chonnam National University Hospital
Phase 4
Completed
100 enrolled